Jones Trading maintains buy rating on ArriVent BioPharma
Benzinga reported that Jones Trading maintained a Buy rating for ArriVent BioPharma.
Story updates
06:58:58 PM UTC
SquawkNews
ArriVent BioPharma Price Target Cut to $22.00/Share From $45.00 by Jones Trading
06:59:07 PM UTC
SquawkNews
Ratings actions from Benzinga: GMT) ArriVent BioPharma Price Target Cut to $22.00/Share From $45.00 by Jones TradingRatings actions from Benzinga